{
    "SPADE_UN_19039": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_19039",
            "Peptide Name": "(GS)4-Ctn[15-34] (Synthetic AMPs, XXA, UCLL1c. Derivative: E10-Ctn[15-34])",
            "Source": "Designed",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GSGSGSGSKKRLKKIFKKPMVIGVTIPF",
            "Sequence Length": 28,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2948.57,
            "PI": 11.43,
            "Hydrophobicity": -0.14,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Júnior NGO, Cardoso MH, Cândido ES, van den Broek D, de Lange N, Velikova N, Kleijn JM, Wells JM, Rezende TMB, Franco OL, de Vries R. 2018",
                    "Reference": "Sci Rep. 2018 Jul 24;8(1):11127. doi: 10.1038/s41598-018-29444-0.PubMed",
                    "Title": "An acidic model pro-peptide affects the secondary structure, membrane interactions and antimicrobial activity of a crotalicidin fragment."
                }
            ],
            "Frequent Amino Acids": "KGS",
            "Absent Amino Acids": "ACDEHNOQUWY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 14,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is 71.43% similar toCrotalicidin[15-34]K: 50%, F: 21%, V: 14%.Activity: active against E. coli ATCC 25922 or KPC+001812446 (MIC 2 ug/ml), K. pneumoniae ATCC 13883 or KPC+001812446 (MIC 2-16 ug/ml), and S. aureus ATCC 25923 (MIC 64 ug/ml).AMP inactivation: like the pro-form of cathelicidin, the attachment of a 10-glutamic propeptide (i.e., E10-Ctn[15-34], led to full inactivation of Ctn[15-34] (Junior et al., 2018).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_12330",
                    "Similarity": 1.0,
                    "Sequence": "GSGSGSGSLKKIFKKPMVIGVTIPF"
                },
                {
                    "SPADE_ID": "SPADE_UN_19947",
                    "Similarity": 1.0,
                    "Sequence": "GSGSGSGSLKKIFKKPMVIGVTIPF"
                },
                {
                    "SPADE_ID": "SPADE_N_05987",
                    "Similarity": 1.0,
                    "Sequence": "KKRLKKIFKKPMVIGVTIPF"
                }
            ]
        }
    }
}